Astrana Health, Inc. (ASTH) vs Xencor, Inc. (XNCR)

A side-by-side comparison of Astrana Health, Inc. and Xencor, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — ASTH vs XNCR

growth of $100 · dividends reinvested · last 10y
ASTH +824.9% (+24.9%/yr)XNCR +10.1% (+1.0%/yr)ASTH compounded faster over this window
Log scale — wide-divergence pair
101001k10kStart $10020182020202220242026$925$110
ASTH XNCR

ASTH vs XNCR: by the numbers

  • •ASTH is the larger company ($1.84B vs $1.80B market cap).
  • •ASTH is profitable (1.05% net margin) while XNCR runs a net loss (-155.59%).
  • •ASTH grew revenue faster over the past five years (53.77% vs 0.47% CAGR).

Metrics side by side

Valuation

MetricASTHXNCR
P/E ratio45.41N/A
Forward P/E26.55N/A
P/S ratio0.4817.17
P/B ratio2.223.58
EV / EBITDA13.52N/A
FCF yield8.61%N/A

Profitability

MetricASTHXNCR
Gross margin9.22%91.63%
Operating margin2.61%-141.35%
Net margin1.05%-155.59%
ROE4.88%-32.46%
ROIC4.13%-33.60%

Growth (annualized)

MetricASTHXNCR
Revenue CAGR (5Y)53.77%0.47%
EPS CAGR (5Y)-15.06%N/A
FCF CAGR (5Y)18.35%N/A
Total return CAGR (5Y)-16.52%-6.46%

Frequently asked

Which has grown faster, ASTH or XNCR?
Over the past five years, ASTH grew revenue faster — ASTH at a 53.77% CAGR versus XNCR at 0.47%.
Is ASTH or XNCR more profitable?
ASTH runs the higher net margin — ASTH at 1.05% versus XNCR at -155.59%.
How have ASTH and XNCR total returns compared?
Over the past 10 years, ASTH delivered 25.17% and XNCR delivered 0.77% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.